Allen Mooney & Barnes Investment Advisors’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-11,700
| Closed | -$884K | – | 159 |
|
|
2026
Q1 | $884K | Buy |
11,700
+22
| +0.2% | +$1.65K | 0.13% | 80 |
|
|
2025
Q4 | $870K | Buy |
11,678
+36
| +0.3% | +$2.63K | 0.13% | 77 |
|
|
2025
Q3 | $786K | Sell |
11,642
-112
| -1% | -$7.43K | 0.12% | 79 |
|
|
2025
Q2 | $766K | Sell |
11,754
-510
| -4% | -$30.6K | 0.13% | 79 |
|
|
2025
Q1 | $758K | Buy |
12,264
+21
| +0.2% | +$1.39K | 0.12% | 81 |
|
|
2024
Q4 | $883K | Sell |
12,243
-33
| -0.3% | -$2.58K | 0.15% | 73 |
|
|
2024
Q3 | $1M | Sell |
12,276
-249
| -2% | -$19.9K | 0.17% | 70 |
|
|
2024
Q2 | $930K | Sell |
12,525
-214
| -2% | -$16K | 0.17% | 71 |
|
|
2024
Q1 | $991K | Sell |
12,739
-79
| -0.6% | -$5.88K | 0.19% | 69 |
|
|
2023
Q4 | $916K | Buy |
12,818
+390
| +3% | +$27.2K | 0.17% | 72 |
|
|
2023
Q3 | $863K | Buy |
12,428
+347
| +3% | +$26.2K | 0.18% | 71 |
|
|
2023
Q2 | $978K | Sell |
12,081
-653
| -5% | -$53.4K | 0.22% | 64 |
|
|
2023
Q1 | $1.03M | Buy |
12,734
+30
| +0.2% | +$2.42K | 0.25% | 62 |
|
|
2022
Q4 | $950K | Sell |
12,704
-1,271
| -9% | -$90.5K | 0.23% | 61 |
|
|
2022
Q3 | $902K | Sell |
13,975
-1,063
| -7% | -$73.6K | 0.24% | 65 |
|
|
2022
Q2 | $1.04M | Sell |
15,038
-700
| -4% | -$52K | 0.27% | 65 |
|
|
2022
Q1 | $1.21M | Buy |
+15,738
| New | +$1.13M | 0.27% | 64 |
|
Other funds holding HOLX
Allen Mooney & Barnes Investment Advisors's HOLX Position: Q2 2026 in Review
Allen Mooney & Barnes Investment Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 11,700 shares — an estimated $884K sold.
Allen Mooney & Barnes Investment Advisors first reported a position in HOLX in Q1 2022 and held it in 17 quarters. The position peaked at $1.21M in Q1 2022. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Allen Mooney & Barnes Investment Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Allen Mooney & Barnes Investment Advisors sold 11,700 Hologic shares in Q2 2026, an estimated $884K.
- Allen Mooney & Barnes Investment Advisors first reported a position in Hologic in Q1 2022 and held it in 17 quarters.
- Allen Mooney & Barnes Investment Advisors's Hologic position peaked at $1.21M in Q1 2022.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Allen Mooney & Barnes Investment Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.